A-Alpha Bio
Business Services · Washington, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
2101 4th Ave Ste 500, Seattle, Washingto...Phone Number
(206) 890-9704Website
www.aalphabio.comRevenue
$14.7 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
2
1
1
About A-Alpha Bio
A-Alpha Bio is a biotechnology company that combines computational tools with yeast experiments to identify potentially therapeutic proteins. The company is based in Seattle, Washington.Explore more
A-Alpha Bio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is A-Alpha Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when A-Alpha Bio launches new products
Check if A-Alpha Bio has recently received funding, and reach out quickly before it becomes old news!
Check out if A-Alpha Bio is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at A-Alpha Bio
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on A-Alpha Bio recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once A-Alpha Bio has new funding data
A-Alpha Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if A-Alpha Bio had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at A-Alpha Bio
Find 3 more new buyers
Compare Similar Companies to A-Alpha Bio
Compare insights from companies similar to A-Alpha Bio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
A-Alpha Bio is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
A-Alpha Bio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about A-Alpha Bio.
A-Alpha Bio financials insights
Gather financial insights about A-Alpha Bio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2019
Angel/Seed
$2.8M
2023
Series A
$51M
2024
Other Financing Round
$14.5M
A-Alpha Bio Tech Stack
A closer look at the technologies used by A-Alpha Bio
Most Recent Scoops
Event
Events, Engineering, Sales, Bioengineering, Laboratory Operations, Pharmaceuticals, Field /Outside Sales, Clinical Operations, Field Marketing, Operations
Event
Events, Engineering, Sales, Bioengineering, Laboratory Operations, Pharmaceuticals, Field /Outside Sales, Clinical Operations, Field Marketing, Operations
Person-Based
Event
Events, Engineering, Research & Development, Training, Machine Learning, Learning & Development, Search, Laboratory Operations, Medical Education & Training, Medical Research, Chemical Engineering, Artificial Intelligence, Clinical Operations, Healthcare Technology, HR Operations, Operations
Event
Product Marketing, Events, Sales, Food & Beverage, Hospitality, Field /Outside Sales, Field Marketing
A-Alpha Bio News & Media
A-Alpha Bio Appoints Troy Lionberger as New Chief Business Officer to Drive Next Phase of Growth
Strategic business leader to build upon A-Alpha Bio’s successful track record of partnering with drug developers of biologics and small molecule degraders to be a broad industry enabler Strategic business leader to build upon A-Alpha Bio’s successful track record of partnering with drug developers of biologics and small molecule degraders to be a broad industry enablerA-Alpha Bio Awarded Additional $14.5M from the Department of Defense to Accelerate Antibody Discovery and Optimization for Likely Biothreats
Funding supports A-Alpha Bio’s continued partnership with Lawrence Livermore National Laboratory to generate large-scale antibody-antigen binding data and train computational models that accelerate drug discovery against an expanded list of possible biological threats Funding supports A-Alpha Bio’s continued partnership with Lawrence Livermore National Laboratory to generate large-scale antibody-antigen binding data and train computational models that accelerate drug discovery against an expandeLife Science Washington Institute Announces 2023 Entrepreneurial Achievement Award Winner
SEATTLE--(BUSINESS WIRE)--Life Science Washington Institute (LSWI), a Life Science Washington affiliate focused on supporting early-stage companies and entrepreneurs in Washington state, announced Dr. David Younger, Ph.D., co-founder and CEO of A-Alpha Bio, as the winner of the Entrepreneurial Achievement Award. Established in 2020, the award celebrates the significant accomplishments of founding leaders from Washington-based life science companies who are reaching milestones, driving innovatioA-Alpha Bio Collaborates with Amgen to Identify and Validate Ligase-Target Pairs for Molecular Glue Discovery
AlphaSeq will be used to interrogate newly discovered interactions between E3 ubiquitin ligases and therapeutic targets to assess glueability and provide structural insights for molecular glue discovery. SEATTLE, Sept. 26, 2023 /PRNewswire-PRWeb/ -- A-Alpha Bio (A-Alpha), a synthetic...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding A-Alpha Bio
Sign Up For FreeTo access detailed company insights
A-Alpha Bio is a biotechnology company that combines computational tools with yeast experiments to identify potentially therapeutic proteins. The company is based in Seattle, Washington.... Read More
